Fed Watchers Will Look For Clues On Hikes, Wages, Trade War
Bloomberg’s David Wilson, stocks editor, and Matt Boesler, Fed reporter, along with Carl Riccadonna, Chief US Economist for Bloomberg Intelligence, discuss what to expect from Federal Reserve Chairman...
17 Jul 201811min
BlackRock CEO Larry Fink: Clients Don't Want Exposure To Crypto
Bloomberg's Erik Schatzker discusses his interview with BlackRock CEO Larry Fink. Gymboree CEO Daniel Griesemer discusses the company's new apparel line and turnaround, after emerging from bankruptcy...
17 Jul 201828min
Bank Stock Weakness Is Signalling Upcoming Downturn: Peabody
Charles Peabody, President of Portales Partners LLC, on bank earnings and why bank stocks have peaked. Ariel Cohen, Senior Fellow at the Atlantic Council, on Trump’s upcoming summit with Putin. Theres...
13 Jul 201829min
Libya's Returning Supply, Saudi Output, Pushing Oil Price Down
John Kilduff, Founding Partner of Again Capital, on why oil prices are on the way down. Joseph Abboud, designer and Chief Creative Director of Men’s Wearhouse, on growth, manufacturing in the U.S., an...
13 Jul 201828min
Pfizer Reversing Price Hikes After Trump Bullying Won’t Last
Max Nisen, Bloomberg Opinion health care columnist, on Pfizer agreeing to delay price increases after Trump called the company out.Vacit Arat, co-founder and President of HIA Technologies Inc., on cre...
12 Jul 201832min
Could See A U.S. And Global Recession By End Of 2019: Sri-Kumar
Komal Sri-Kumar, president and founder of Sri-Kumar Global Strategies and Bloomberg Opinion columnist, on how trade wars could spur currency devaluations. Vijay Govindarajan, Coxe Distinguished Profes...
10 Jul 201826min
EU Rejection Poses Bigger Danger For May Than Brexit Rebellion
Clive Crook, Bloomberg Opinion Editor, on outlook for Theresa May and Brexit, following the departure of top Brexiter Boris Johnson.Robert Lawrence, Professor of International Trade and Investment at ...
9 Jul 201828min
Amazon’s Health Care Threat Just Became A Reality: Ovide, Nisen
Bloomberg Opinion’s Max Nisen, health care columnist, and Shira Ovide, technology columnist, on Amazon buying Pillback.Chris Whalen, Chairman of Whalen Global Advisors, on bank stocks continued losing...
9 Jul 201829min
